Moreover, it is found that lithium, a popular treatment for manic episodes [33], can inhibit glycogen synthase kinase 3β (GSK3β) and facilitate the degradation of NR1D1 [34]. This evidence concerns the gene NR1D1 and manic or hypomanic episode.